Last Updated: Thursday, October 18, 2012, 15:24
AstraZeneca Pharma India on Thursday launched its patented antiplatelet drug Brilinta, used to prevent heart attack, after receiving approval from the Drug Controller General of India (DCGI).
Last Updated: Monday, September 13, 2010, 00:00
The 3-yr research will see scientists teaming up to seek new treatments for diabetic retinopathy.
Last Updated: Sunday, February 07, 2010, 00:00
AstraZeneca has struck a deal with the commercial arm of a British charity to try and develop a new class of a "cancer metabolism" drugs.